Published in:
01-03-2020 | Helicobacter Pylori | Stomach (P Malfertheiner, Section Editor)
Burden of Gastroduodenal Diseases from the Global Perspective
Published in: Current Treatment Options in Gastroenterology | Issue 1/2020
Login to get accessAbstract
Purpose of review
We reviewed the recent medical literature to show global burden of gastroduodenal disease, potential strategies, and further perspectives.
Recent findings
Gastrointestinal and liver diseases are growing health problems, and cause more than 8 million deaths per year worldwide; encompass a range of long-term health conditions, such as digestive cancers, gastroesophageal reflux disease, Helicobacter pylori infection, peptic ulcer disease, liver diseases, inflammatory bowel disease, coeliac disease, and functional gastrointestinal disorders. Scientific knowledge demonstrates that the noncommunicable disease burden can be greatly reduced if cost-effective preventive and curative actions, along with interventions for prevention and control of noncommunicable diseases already available, are implemented in an effective and balanced manner.
Summary
Future research will have to elaborate on simple methods for preselection of patients at high risk to allow their implementation in strategies and respect all demand of cost-effectiveness. Understanding trends in GI illnesses could be helpful to meet the needs of patients and decrease the disease burden.